<DOC>
	<DOCNO>NCT00847691</DOCNO>
	<brief_summary>The clinical histological diagnosis sarcoma often difficult . The identification chromosomal molecular anomaly , amplification , deletion fusion gene powerful help establish correct diagnosis sarcoma benign counterpart . However , cost cytogenetic molecular technique detection alteration often limitation use . The aim study evaluate direct cost molecular technique comparison cost would generate appropriate therapy care management patient case erroneous diagnosis .</brief_summary>
	<brief_title>GENSARC 2008 : Medical Economic Evaluation Molecular Detection FISH ( Fluorescent Situ Hybridization ) PCR ( Polymerase Chain Reaction ) Sarcomas Specific Translocations Amplifications .</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma</mesh_term>
	<criteria>patient biopsy excision sarcoma ( suspect diagnose ) sample review pathologist freeze sample clinical data available opposition patient</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>economic evaluation</keyword>
	<keyword>diagnostics</keyword>
	<keyword>sarcoma</keyword>
</DOC>